20-35115584-G-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_018217.3(EDEM2):​c.1586C>A​(p.Ala529Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,706 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00011 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0000082 ( 0 hom. )

Consequence

EDEM2
NM_018217.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.64
Variant links:
Genes affected
EDEM2 (HGNC:15877): (ER degradation enhancing alpha-mannosidase like protein 2) In the endoplasmic reticulum (ER), misfolded proteins are retrotranslocated to the cytosol and degraded by the proteasome in a process known as ER-associated degradation (ERAD). EDEM2 belongs to a family of proteins involved in ERAD of glycoproteins (Mast et al., 2005 [PubMed 15537790]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03666067).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EDEM2NM_018217.3 linkuse as main transcriptc.1586C>A p.Ala529Glu missense_variant 11/11 ENST00000374492.8 NP_060687.2 Q9BV94-1
EDEM2NM_001145025.2 linkuse as main transcriptc.1475C>A p.Ala492Glu missense_variant 10/10 NP_001138497.1 Q9BV94-2
MMP24-AS1-EDEM2NM_001355008.2 linkuse as main transcriptc.1463C>A p.Ala488Glu missense_variant 15/15 NP_001341937.1
EDEM2NR_026728.2 linkuse as main transcriptn.1880C>A non_coding_transcript_exon_variant 10/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EDEM2ENST00000374492.8 linkuse as main transcriptc.1586C>A p.Ala529Glu missense_variant 11/111 NM_018217.3 ENSP00000363616.3 Q9BV94-1
EDEM2ENST00000374491.3 linkuse as main transcriptc.1475C>A p.Ala492Glu missense_variant 10/101 ENSP00000363615.2 Q9BV94-2

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
151812
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000413
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000318
AC:
8
AN:
251470
Hom.:
0
AF XY:
0.0000368
AC XY:
5
AN XY:
135912
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000821
AC:
12
AN:
1461894
Hom.:
0
Cov.:
31
AF XY:
0.00000688
AC XY:
5
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.000358
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
151812
Hom.:
1
Cov.:
32
AF XY:
0.000135
AC XY:
10
AN XY:
74172
show subpopulations
Gnomad4 AFR
AF:
0.000413
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000142
Hom.:
0
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 26, 2024The c.1586C>A (p.A529E) alteration is located in exon 11 (coding exon 11) of the EDEM2 gene. This alteration results from a C to A substitution at nucleotide position 1586, causing the alanine (A) at amino acid position 529 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
11
DANN
Benign
0.61
DEOGEN2
Benign
0.0096
T;.
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.68
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.62
T;T
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.037
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;.
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.43
N;N
REVEL
Benign
0.076
Sift
Benign
0.76
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.18
MutPred
0.14
Gain of solvent accessibility (P = 0.0456);.;
MVP
0.44
MPC
0.39
ClinPred
0.014
T
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.020
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs778066185; hg19: chr20-33703387; API